Skip to content

Improving Germline Testing in At-Risk Patients With Prostate Cancer

IMPRINT: A Pilot Study to Improve Germline Testing in At-Risk Patients With Prostate Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05470036
Acronym
IMPRINT
Enrollment
50
Registered
2022-07-22
Start date
2022-09-27
Completion date
2025-09-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate cancer, Germline testing, Education, Video

Brief summary

A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.

Detailed description

This is a prospective single arm quality improvement initiative for the use of a standardized educational intervention on germline testing in prostate cancer to improve the rates of germline genetic testing among patients recommended for testing. Patients who consent to the study will undergo a one-on-one education session regarding the rationale and the benefits/risks of germline testing. Following the educational session, if a patient wishes to proceed with testing, they will sign the standard consent to proceed with germline testing via a commercial assay.

Interventions

BEHAVIORALEducational intervention.

Educational intervention with trained educator on overview, rationale, implications, and risks and benefits of germline testing in prostate cancer.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Men, age greater than or equal to 18 years of age. 2. Diagnosis of prostate cancer of any histology. 3. Must meet NCCN guidelines for germline testing

Exclusion criteria

1. Have had prior germline testing. 2. Have somatic genetic testing that is positive for a possible germline variant.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Agreeing to Proceed With Germline Testing Among Those Approached With the Educational Intervention.Within 1 yearGermline genetic testing among adult prostate cancer patients who are recommended to receive germline testing per NCCN guidelines.

Secondary

MeasureTime frameDescription
Patient Baseline Knowledge of Germline TestingBaselineAssessment via baseline knowledge questionnaire. Survey Title: Patient Survey on Germline Testing in Prostate Cancer Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge
Patient Attitudes Towards Germline Testing and Assess the Impact of an Education Interventional on Patient Perceptions of Germline TestingWithin 18 monthsAssessment via post intervention questionnaire. Survey Title: Patient Post-Education Patient Survey Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge
Number of Participants With Pathogenic Germline Mutationswithin 18 monthsAssessment via tabulation of all germline pathogenic, likely pathogenic mutations and and variants of uncertain significance.
Patient Knowledge of Germline Testing After the Educational Intervention.within 18 monthsAssessment via post intervention knowledge questionnaire. Survey Title: Patient Survey on Germline Testing in Prostate Cancer Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRana McKay, MD

UCSD

Participant flow

Participants by arm

ArmCount
Education Intervention Group
In-clinic educational session on germline testing in prostate cancer with a trained educator including video intervention.
50
Total50

Baseline characteristics

CharacteristicEducation Intervention Group
Age, Continuous68 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
45 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
Family history
Family history of cancer
35 Participants
Family history
No family history of cancer
15 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
39 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
50 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Number of Participants Agreeing to Proceed With Germline Testing Among Those Approached With the Educational Intervention.

Germline genetic testing among adult prostate cancer patients who are recommended to receive germline testing per NCCN guidelines.

Time frame: Within 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Educational Intervention GroupNumber of Participants Agreeing to Proceed With Germline Testing Among Those Approached With the Educational Intervention.41 Participants
Secondary

Number of Participants With Pathogenic Germline Mutations

Assessment via tabulation of all germline pathogenic, likely pathogenic mutations and and variants of uncertain significance.

Time frame: within 18 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Educational Intervention GroupNumber of Participants With Pathogenic Germline Mutations5 Participants
Secondary

Patient Attitudes Towards Germline Testing and Assess the Impact of an Education Interventional on Patient Perceptions of Germline Testing

Assessment via post intervention questionnaire. Survey Title: Patient Post-Education Patient Survey Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge

Time frame: Within 18 months

ArmMeasureValue (MEAN)
Educational Intervention GroupPatient Attitudes Towards Germline Testing and Assess the Impact of an Education Interventional on Patient Perceptions of Germline Testing9.2 Units on a scale
Secondary

Patient Baseline Knowledge of Germline Testing

Assessment via baseline knowledge questionnaire. Survey Title: Patient Survey on Germline Testing in Prostate Cancer Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge

Time frame: Baseline

ArmMeasureValue (MEAN)
Educational Intervention GroupPatient Baseline Knowledge of Germline Testing9.1 Units on a scale
Secondary

Patient Knowledge of Germline Testing After the Educational Intervention.

Assessment via post intervention knowledge questionnaire. Survey Title: Patient Survey on Germline Testing in Prostate Cancer Minimum Values: 0 (No knowledge) Maximum Values: 11 (Highest knowledge) Higher score = higher knowledge

Time frame: within 18 months

ArmMeasureValue (MEAN)
Educational Intervention GroupPatient Knowledge of Germline Testing After the Educational Intervention.9.2 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026